RRM2B and lung carcinoma: RRM2B aberrations in this study did not show any prognostic impact, in agreement with one clinical study by Uramoto et al. (2006) [42] that found no support for an association between RRM2B protein expression and survival outcome in stage I-III lung cancer patients.